A Randomized, Double-Blind, Placebo-Controlled Trial of Spironolactone on Carotid Intima-Media Thickness in Nondiabetic Hemodialysis Patients
Clinical Journal of the American Society of Nephrology - United States
doi 10.2215/cjn.09421209
Full Text
Open PDFAbstract
Available in full text
Date
June 3, 2010
Authors
Publisher
American Society of Nephrology (ASN)